Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-CD19, FMC63 scFv-8A-F9Z CAR Vector   (CAT#: GTVCR-WQ1210MR)

This product GTVCR-WQ1210MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting CD19. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Chimeric
RefSeq NM_001178098.2
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 930
UniProt ID P15391
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-CD19, FMC63 scFv-8A-F9Z CAR Vector (GTVCR-WQ1210MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1157MR IVTScrip™ pSP6-VEE-mRNA-Anti-CX3CL1, E-6011 Vector Vector E-6011
GTVCR-WQ1909MR IVTScrip™ pSP6-VEE-mRNA-Anti-PDGFRA, MEDI-575 Vector Vector MEDI-575
GTVCR-WQ367MR IVTScrip™ pT7-VEE-mRNA-Anti-IL6, ALD-518 Vector Vector ALD-518
GTVCR-WQ716MR IVTScrip™ pSP6-VEE-mRNA-Anti-Factor VIII substitute, BIIB031 Vector Vector BIIB031
GTVCR-WQ1547MR IVTScrip™ pT7-VEE-mRNA-Anti-MUC1, IMMU-107 Vector Vector IMMU-107
GTVCR-WQ1487MR IVTScrip™ pT7-VEE-mRNA-Anti-IFNA1&IFNB1, IFN-alpha-REC Vector Vector IFN-alpha-REC
GTVCR-WQ534MR IVTScrip™ pSP6-VEE-mRNA-Anti-C3&C4, APT070 Vector Vector APT070
GTVCR-WQ1082MR IVTScrip™ pSP6-VEE-mRNA-Anti-HA, CT-P22 Vector Vector CT-P22
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.